Table 2.

Clinical outcome of the patients

Variable	Amiodarone treated patients (*n = 46*)
Outcome	Baseline	After 24 h	Difference	P-value
HR	121.0(116.5140.0)^b	91.5(89.3108.0)		< 0.001^d
MAP	98.4 ± 9.3 ^a	89.1 ± 9.1	9.3 ± 8.9	< 0.001 ^c
CI	3.66 ± 0.92 ^a	3.29 ± 1.10	0.37 ± 0.95	0.013 ^c
SVR	1088.6 ± 373.9 ^a	1193.7 ± 403.5	− 105.0 ± 312.8	0.109 ^c
SVI	31.7 ± 8.5 ^a	33.8 ± 9.4	−2.1 ± 6.9	0.054 ^c
NE	11.0(10.0,12.0) ^b	9.0(8.0,12.0)		0.023 ^d
LACTATE	25.5(20.8,33.0) ^b	19.5(11.8,32.3)		0.057 ^d

^a Mean ± SD, ^b Median (Q1, Q3), ^c paired samples t-test, ^d Wilcoxon’s signed-rank test